Home Cart Sign in  
Chemical Structure| 410536-97-9 Chemical Structure| 410536-97-9

Structure of Sirtinol
CAS No.: 410536-97-9

Chemical Structure| 410536-97-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sirtinol is a sirtuin (SIRT) inhibitor with IC50 values of 48 μM, 57.7 μM, and 131 μM for ySir2, hSIRT2, and hSIRT2, respectively.

Synonyms: Sir Two Inhibitor Naphthol

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sirtinol

CAS No. :410536-97-9
Formula : C26H22N2O2
M.W : 394.47
SMILES Code : O=C(NC(C1=CC=CC=C1)C)C2=CC=CC=C2/N=C/C3=C4C=CC=CC4=CC=C3O
Synonyms :
Sir Two Inhibitor Naphthol
MDL No. :MFCD00810186
InChI Key :UXJFDYIHRJGPFS-UHFFFAOYSA-N
Pubchem ID :2827646

Safety of Sirtinol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Sirtinol

epigenetics

Isoform Comparison

Biological Activity

Description
Sirtinol is an inhibitor of sirtuin (SIRT), with IC50 values of 48 μM, 57.7 μM, and 131 μM for ySir2, hSIRT2, and hSIRT2, respectively[1][2][3][4].
Target
  • SIRT1

    SIRT1, IC50:131 μM

  • SIRT2

    SIRT2, IC50:38 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
SkBr3 cells 25 μM 6 hours To investigate the inhibitory effect of Sirtinol on E2 and G-1 induced p53 acetylation and p21 expression, results showed that Sirtinol could prevent the inhibition of p53 acetylation and p21 expression by E2 and G-1. PMC4650744
CAFs (cancer-associated fibroblasts) 25 μM 6 hours To investigate the inhibitory effect of Sirtinol on E2 and G-1 induced p53 acetylation and p21 expression, results showed that Sirtinol could prevent the inhibition of p53 acetylation and p21 expression by E2 and G-1. PMC4650744
Primary cortical neurons 20 μmol/L 24 hours To evaluate the effect of Sirtinol on SalB-induced SIRT1 and Nrf2 signaling pathways, results showed that Sirtinol significantly suppressed SalB-induced SIRT1 and Nrf2 expression PMC6286712
NRVMs 25 μM 2 hours Inhibit SIRT1 activity, block icariin-induced cardioprotection against SI/R injury PMC6177614

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Experimental subarachnoid hemorrhage model Left lateral ventricle injection 3 mg/kg Once weekly for 3 weeks Sirtinol inhibited the expression and activation of SIRT1 pathways after SAH, leading to aggravated brain injury after SAH. PMC5133967
nude mice SkBr3 xenograft model intramuscular injection 2 mmol/l, 30 μl/kg Single dose 2 hours before SAH induction To investigate the inhibitory effect of Sirtinol on G-1 induced tumor growth, results showed that Sirtinol could prevent G-1 induced tumor growth. PMC4650744
Rats Subarachnoid hemorrhage model Intraventricular injection 60 mg/kg Every other day for one month To evaluate the effect of Sirtinol on the neuroprotective effects of SalB, results showed that Sirtinol significantly reversed the antioxidant and neuroprotective effects of SalB PMC6286712
Rats Subarachnoid hemorrhage model Intraventricular injection 2 mmol/L, 30 μL/kg Single administration 2 hours before SAH induction Sirtinol significantly reversed the protective effects of SalB against SAH-induced oxidative damage and neural injury. PMC6286712
Mice Myocardial ischemia/reperfusion injury model Intraperitoneal injection 15 µg twice every 3 days Inhibit SIRT1 activity, block icariin-induced cardioprotection against myocardial ischemia/reperfusion injury PMC6177614

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.54mL

0.51mL

0.25mL

12.68mL

2.54mL

1.27mL

25.35mL

5.07mL

2.54mL

References

 

Historical Records

Categories